Cargando…
Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients
BACKGROUND: In Egypt, the prevalence of chronic hepatitis C (CHC) infection is 13.8% of whole population and about 80% of the patients with hepatocellular carcinoma have underling hepatitis C. AIM: This study was designed to assess the diagnostic value of plasma miR-122 and miR-21 in patients with C...
Autores principales: | Demerdash, Hala M., Hussien, Hend M., Hassouna, Ehab, Arida, Emad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469990/ https://www.ncbi.nlm.nih.gov/pubmed/28642869 http://dx.doi.org/10.1155/2017/1806069 |
Ejemplares similares
-
MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma
por: El Mahdy, Hussein Ahmed, et al.
Publicado: (2019) -
MicroRNAs as Predictor Markers for Response to Interferon Treatment of Chronic Hepatitis C Genotype-4 in Egyptian Patients
por: Motawi, Tarek M. K., et al.
Publicado: (2015) -
Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians
por: Youssef, Samar Samir, et al.
Publicado: (2022) -
MicroRNA155 Expression in Different Phenotypes and Genotypes of Behçet’s Disease in a Sample of Egyptian Patients
por: Hassouna, Sally S., et al.
Publicado: (2020) -
Detection of exosomal miR-18a and miR-222 levels in Egyptian patients
with hepatic cirrhosis and hepatocellular carcinoma
por: Elghoroury, Eman A, et al.
Publicado: (2022)